The information in this Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and notes. All references to "Notes" are to the accompanying condensed consolidated financial statements and notes included in this Quarterly Report on Form 10-Q ("Form 10-Q").

Cautionary Note Regarding Forward-Looking Statements

References in this report to "IEC," the "Company," "we," "our," or "us" mean IEC Electronics Corp. and its subsidiaries except where the context otherwise requires. This Form 10-Q contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. These forward-looking statements include, but are not limited to, statements regarding future sales and operating results, future prospects, the capabilities and capacities of business operations, any financial or other guidance and all statements that are not based on historical fact, but rather reflect our current expectations concerning future results and events. The ultimate correctness of these forward-looking statements is dependent upon a number of known and unknown risks and events and is subject to various uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.

The following important factors, among others, could affect future results and events, causing those results and events to differ materially from those views expressed or implied in our forward-looking statements: the impact of the COVID-19 pandemic on our business, including our supply chain, workforce and customer demand; business conditions and growth or contraction in our customers' industries, the electronic manufacturing services industry and the general economy; our ability to control our material, labor and other costs; our dependence on a limited number of major customers; uncertainties as to availability and timing of governmental funding for our customers; the impact of government regulations, including U.S. Food and Drug Administration regulations; unforeseen product failures and the potential product liability claims that may be associated with such failures; technological, engineering and other start-up issues related to new programs and products; variability and timing of customer requirements; the potential consolidation of our customer base; availability of component supplies; dependence on certain industries; the ability to realize the full value of our backlog; the types and mix of sales to our customers; litigation and governmental investigations; intellectual property litigation; variability of our operating results; our ability to maintain effective internal controls over financial reporting; the availability of capital and other economic, business and competitive factors affecting our customers, our industry and business generally; failure or breach of our information technology systems; and natural disasters. Any one or more of such risks and uncertainties could have a material adverse effect on us or the value of our common stock. For a further list and description of various risks, relevant factors and uncertainties that could cause future results or events to differ materially from those expressed or implied in our forward-looking statements, see the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections in this Form 10-Q, our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, and our other filings with the Securities and Exchange Commission (the "SEC").

All forward-looking statements included in this Form-10-Q are made only as of the date indicated or as of the date of this Form 10-Q. We do not undertake any obligation to, and may not, publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or which we hereafter become aware of, except as required by law. New risks and uncertainties arise from time to time and we cannot predict these events or how they may affect us and cause actual results to differ materially from those expressed or implied by our forward-looking statements. Therefore, you should not rely on our forward-looking statements as predictions of future events. When considering these risks, uncertainties and assumptions, you should keep in mind the cautionary statements contained in this report and any documents incorporated herein by reference. You should read this document and the documents that we reference in this Form 10-Q completely and with the understanding that our actual future results may be materially different from what we expect. All forward-looking statements attributable to us are expressly qualified by these cautionary statements.



                                       29

  Table of Contents

Overview

IEC Electronics Corp. ("IEC," "we," "our," "us," or the "Company") conducts business directly, as well as through its subsidiaries, IEC Electronics Corp-Albuquerque ("Albuquerque"), and IEC Analysis & Testing Laboratory, LLC ("ATL").

We are a premier provider of electronic manufacturing services ("EMS") to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. We specialize in delivering technical solutions for the custom manufacturing, product configuration, and verification testing of highly engineered complex products that require a sophisticated level of manufacturing to ensure quality and performance.

Within the EMS sector, we have unique capabilities which allow our customers to rely on us to solve their complex challenges, minimize their supply chain risk and deliver full system solutions for their supply chain. These capabilities include, among others:

Our engineering services include the design, development, and fabrication of

? customized stress testing platforms to simulate a product's end application,

such as thermal cycling and vibration, in order to ensure reliable performance

and avoid catastrophic failure when the product is placed in service.

Our vertical manufacturing model offers customers the ability to simplify their

supply chain by utilizing a single supplier for their critical components

including complex printed circuit board assembly ("PCBA"), precision

? metalworking, and interconnect solutions. This service model allows us to

control the cost, lead time, and quality of these critical components which are

then integrated into full system assemblies and minimizes our customers' supply

chain risk.

We provide direct order fulfillment services for our customers by integrating

with their configuration management process to obtain their customer orders,

? customize the product to the specific requirements, functionally test the

product and provide verification data, and direct ship to their end customer in

order to reduce time, cost, and complexity within our customer's supply chain.

We believe we are the only EMS provider with an on-site laboratory that has

been approved by the Defense Logistics Agency ("DLA") for their Qualified

Testing Supplier List ("QTSL") program which deems the site suitable to conduct

? various QTSL and military testing standards including counterfeit component

analysis and environmental testing to qualify a part fit for use. In addition,

this advanced laboratory is utilized for complex design analysis and

manufacturing process development to solve challenges and accelerate our

customers' time to market.

We are a 100% U.S. manufacturer which attracts customers who are unlikely to utilize offshore suppliers due to the proprietary nature of their products, governmental restrictions or volume considerations. Our locations include:

Newark, New York - Located approximately one hour east of Rochester, New York,

our Newark locations contain our corporate headquarters and our largest

? manufacturing location providing complex circuit board manufacturing,

interconnect solutions, and system-level assemblies along with an on-site

material analysis laboratory for advanced manufacturing process development.

Rochester, New York - Focuses on precision metalworking services including

complex metal chassis and assemblies. In October 2020, we acquired an

? additional industrial and office building, the Jetview building, located in

Rochester, New York, which is expected to be occupied during the fourth quarter

of fiscal 2021.

Albuquerque, New Mexico - Specializes in the aerospace and defense markets with

? complex circuit board and system-level assemblies along with a state of the art

analysis and testing laboratory which conducts root cause failure analysis,

reliability, inspection and authenticity testing.

We excel at complex, highly engineered products that require sophisticated manufacturing support where quality and reliability are of paramount importance. With our customers at the center of everything we do, we have created a high-intensity, rapid response culture capable of reacting and adapting to their ever-changing needs. Our customer-centric approach offers a high degree of flexibility while simultaneously complying with rigorous quality and on-time delivery standards.



                                       30

  Table of Contents


We proactively invest in areas we view as important for our continued long-term growth. Excluding the recently acquired Jetview building, all of our remaining locations are ISO 9001:2015 certified and ITAR registered. We are Nadcap accredited and AS9100D certified at our Newark and Albuquerque locations to support the stringent quality requirements of the aerospace industry. Our Newark location is ISO 13485 certified to serve the medical sector and is an approved supplier by the National Security Agency under the COMSEC standard regarding communications security. Our analysis and testing laboratory in Albuquerque is ISO 17025 accredited, an IPC-approved Validation Services Qualified Test Laboratory, and we believe is the only on-site EMS laboratory that has been approved by the DLA for their QTSL program which deems the site suitable to conduct various QTSL and military testing standards including counterfeit component analysis and environmental testing to qualify a part fit for use. At our Albuquerque location, we also perform work per NASA-STD-8739 and J-STD-001ES space standards.

The technical expertise of our experienced workforce enables us to build some of the most advanced electronic, wire and cable, interconnect solutions, and precision metal systems sought by original equipment manufacturers ("OEMs").

Entry into Merger Agreement

On August 12, 2021, we entered into a definitive merger agreement (the "Merger Agreement") with Creation Technologies International Inc. ("Parent"), Creation Technologies Inc. (the "Guarantor") and CTI Acquisition Corp., a wholly-owned subsidiary of Parent ("Purchaser"), under which Purchaser will acquire all outstanding shares of IEC common stock for $15.35 per share in cash, representing an implied fully diluted equity value of approximately $174 million. The transaction is structured as a tender offer followed by a merger (collectively, the "Transaction"). The Transaction, which was unanimously approved by our Board of Directors upon recommendation by a Special Committee of the Board, is expected to close by early October 2021 assuming the satisfaction of all conditions.

Under the terms of the Merger Agreement, our Board of Directors, with the assistance of its financial advisor, will conduct a 35-day "go-shop" expiring September 16, 2021, during which it will actively initiate, solicit, facilitate, encourage and evaluate alternative acquisition proposals, and potentially enter into negotiations with any parties that offer alternative acquisition proposals. We will have the right to terminate the Merger Agreement to accept a superior proposal, subject to the terms and conditions of the Merger Agreement. If we terminate the Merger Agreement, we must pay Parent a customary termination fee that varies in amount depending on whether or not the superior proposal results from the go-shop. In addition, the Merger Agreement provides Parent a customary right to match a superior proposal. There can be no assurance that this "go-shop" process will result in a superior proposal or that the Transaction with Parent or any other transaction will be approved or completed. Except as required by law, we do not intend to disclose developments with respect to the solicitation process unless and until the Board of Directors makes a determination requiring further disclosure.

Under the terms of the Merger Agreement, Purchaser will commence a tender offer to purchase all of the outstanding shares IEC common stock for $15.35 per share in cash (the "Offer"). The proposed Transaction is subject to, among other customary closing conditions, the tender to Purchaser by our stockholders of shares representing more than two-thirds of the total number of our outstanding shares, the expiration or termination of the Hart-Scott-Rodino waiting period, and other customary conditions. Following completion of the Transaction, we will become a privately-held company and our shares of common stock will no longer be listed on any public market.





See Item IA. Risk Factors for further discussion of the risks related to the
Transaction.







                                       31

  Table of Contents



COVID-19 Pandemic

The COVID-19 pandemic continues to disrupt supply chains and affect production and sales across a range of industries. The ultimate extent of the impact of the COVID-19 pandemic on our supply chain, workforce, customer demand, operations and financial performance will depend on certain developments, including the duration and spread of the outbreak and variants, the effectiveness of vaccines and speed of distribution, as well as the impact on our customers, employees and vendors all of which remain uncertain and cannot be predicted.

In accordance with the Department of Defense guidance issued in March 2020, designating the Defense Industrial Base as a critical infrastructure workforce, our production facilities have continued to operate in support of essential products and services required to meet national security commitments to the U.S. government and the U.S. military.

Please see Item 1A. Risk Factors in this report for additional information regarding certain risks associated with the COVID-19 pandemic.

Supply Chain

The COVID-19 pandemic has created a level of uncertainty around the availability of raw material components in future periods. We are aware of some component manufacturers that have continued to temporarily shut down, as a result of COVID-19 related illnesses impacting their employee populations or to comply with government mandates. Due to the lifesaving and mission critical nature of the products we support, many of our suppliers and the related programs were given certain priority ratings, which helped ensure the required supply of material.

We are continually assessing potential supply chain impacts and working with our distribution partners to identify existing, on hand stock that we can access. We are also working with our customer base to determine their interest in participating in inventory pre-purchase arrangements, which would be funded through additional customer deposits.

Workforce

The safety and well-being of our employees has been, and continues to be, our top priority, especially during the COVID-19 pandemic. Although we are deemed an essential business based on the lifesaving and mission critical products we support, and we have remained fully operational throughout the pandemic, we chose early on to ask our non-essential employees to work from home in order to reduce the employee density in our facilities. As circumstances have allowed and in accordance with applicable guidelines, we have assigned non-essential employees into two groups, working alternating weeks in the office to maintain social distancing. In support of those working on site, we have taken numerous actions to help provide for a safe work environment and allow for appropriate social distancing, where possible. Some examples of the actions we have taken include, but are not limited to, the following:

? Adjusted shift start and end times to limit the number of people entering and

exiting our facilities simultaneously;

? Adjusted break and lunch times to reduce the number of people in common areas;

? Designated stairwells and walkways as one-way to ensure employees are not

passing each other in tight quarters; and

Implemented additional cleaning protocols to ensure work surfaces, high touch

? areas and common spaces are routinely cleaned and disinfected in accordance

with guidelines from the Centers for Disease Control and Prevention.

We have also developed contingency plans in the event that one of our employees tests positive for COVID-19. During the first quarter of fiscal 2021, we experienced employee absenteeism across several of our manufacturing facilities due to COVID-19, largely related to contact tracing precautions rather than positive cases. This resulted in underutilization on the production floor for a portion of the first quarter of fiscal 2021. During the third quarter of fiscal 2021, however, we saw employee absenteeism remain at more normal levels. We expect to continue to align practices to remain in conformance with state and federal guidelines.



                                       32

  Table of Contents

Customer Demand

Due to the nature of the lifesaving and mission critical products that we support, the majority of our customers are also deemed to be essential businesses and have remained operational throughout the pandemic. At a macro level, we have seen some indices of demand normalizing to pre-COVID-19 pandemic levels. However, certain customers have requested that a portion of their demand be moved out to future periods beyond fiscal 2021. To date, these requests represent a small percentage of our current backlog and we do not expect to see a material impact from these requests. We continue to work in partnership with our customers to continually assess any potential impacts from the pandemic and opportunities to mitigate risk.

Three Months Results



A summary of selected income statement amounts for the three months ended
follows:


                                              Three Months Ended
                                             July 2,      June 26,
         Income Statement Data                 2021         2020
(in thousands)
Net sales                                   $   49,370    $  47,364
Gross profit                                     5,235        6,642
Selling and administrative expenses              3,357        3,678
Interest expense                                   587          300

Income before provision for income taxes 1,291 2,664 Provision for income taxes

                         265          550
Net income                                  $    1,026    $   2,114




A summary of sales, according to the market sector within which our customers
operate, follows:




                                Three Months Ended

                                July 2,       June 26,
Percent of Sales by Sector       2021           2020

Aerospace and Defense              76 %            59 %
Medical                            14 %            28 %
Industrial                         10 %            13 %
                                  100 %           100 %



Revenue increased in the third quarter of fiscal 2021 by $2.0 million or 4.2% as compared to the third quarter of the prior fiscal year. Revenues from the aerospace & defense sector increased $9.6 million, revenue from the medical sector decreased $6.4 million and revenue from the industrial sector decreased $1.2 million.

Various increases and decreases in sales to our aerospace & defense customers resulted in a net increase of $9.6 million in the third quarter of fiscal 2021 compared to the same period of the prior fiscal year. A new customer resulted in an increase of $9.9 million. Production ramp up for two customers resulted in an increase in revenue of $5.5 million. These increases were partially offset by reductions to revenue from various customers who experienced material and engineering delays and various program delays totaling $6.0 million. The remaining change is due to $0.2 million of net increases in demand at various customers.

The medical sector saw a decrease of $6.4 million in the third quarter of fiscal 2021 compared to the same period of the prior fiscal year. We saw decreases in customer demand of $7.0 million and decreases related to disengaging with one customer of $1.2 million. These decreases were primarily due to increased demand in the prior fiscal year period related to the COVID-19 pandemic and were partially offset by increases related to a new customer and various increases in demand aggregating $1.8 million. We continue to expect some volatility in the medical sector going forward.





                                       33

  Table of Contents

The net decrease in the industrial sector of $1.2 million in the third quarter of fiscal 2021 compared to the same period of the prior fiscal year, resulted primarily from the net decreases in demand from various customers.

Gross profit for the third quarter of fiscal 2021 was $5.2 million, or 10.6% of sales compared to $6.6 million, or 14.0% of sales in the third quarter of fiscal 2020.

Selling and administrative expenses decreased $0.3 million in the third quarter of fiscal 2021 compared to the third quarter of the prior fiscal year and represented 6.8% and 7.8% of sales in each of the periods, respectively.

Interest expense increased by $0.3 million in the third quarter of fiscal 2021 compared to the same quarter of the prior fiscal year. The weighted average interest rate on our debt was 0.18% higher during the third quarter of fiscal 2021 compared to the third quarter of the prior fiscal year. Our average outstanding debt balances increased by $9.1 million in the third quarter of fiscal 2021 compared to the third quarter of fiscal 2020 due to higher balances on our revolving credit facility and outstanding amounts under the master equipment lease with M&T Bank (the "Master Lease"). Cash paid for interest on credit facility debt was approximately $0.3 million and $0.2 million during the third quarters of fiscal 2021 and fiscal 2020, respectively. Detailed information regarding our borrowings is provided in Note 6-Credit Facilities.

With respect to tax payments, in the near term, we expect to benefit from sizable net operating loss ("NOL") carryforwards for federal income tax purposes. During the third quarter of fiscal 2021, we paid minimal taxes. At the end of fiscal 2020, the gross NOL carryforwards amounted to approximately $15.9 million. The NOL carryforwards expire in 2036, unless utilized prior to these dates.





Year to Date Results



A summary of selected income statement amounts for the nine months ended
follows:


                                              Nine Months Ended
                                             July 2,     June 26,
Income Statement Data                         2021         2020
(in thousands)
Net sales                                   $ 142,211    $ 136,269
Gross profit                                   14,287       17,384
Selling and administrative expenses            10,362       10,194
Interest expense                                1,589        1,111

Income before provision for income taxes 2,336 6,079 Provision for income taxes

                        121        1,253
Net income                                  $   2,215    $   4,826






                                       34

  Table of Contents

A summary of sales, according to the market sector within which our customers
operate, follows:




                           Nine Months Ended

                          July 2,       June 26,
% of Sales by Sector       2021           2020

Aerospace & Defense          69 %            60 %
Medical                      20 %            26 %
Industrial                   11 %            14 %
                            100 %           100 %



Revenue increased in the first nine months of fiscal 2021 by $5.9 million or 4.4% as compared to the first nine months of the prior fiscal year. Revenues from the aerospace & defense sector increased $16.4 million, revenue from the medical sector decreased $7.0 million and revenue from the industrial sector decreased $3.4 million.

Various increases and decreases in sales to our aerospace & defense customers resulted in a net increase of $16.4 million in the first nine months of fiscal 2021 compared to the same period of the prior fiscal year. A new customer resulted in an increase of $19.8 million. Net demand increases at various customers resulted in an increase of $1.5 million. These increases were partially offset by reductions to revenue from various customers related to customer program delays of $4.9 million.

The medical sector saw a decrease of $7.0 million in the first nine months of fiscal 2021 compared to the same period of the prior fiscal year. We saw increases of $5.2 million related to increases in demand with various customers and an increase of $1.5 million related to a new customer. These increases were offset by decreases in demand from various customers of $11.5 million and a decrease due to disengaging with a customer of $2.2 million. These decreases were primarily due to increased demand in the prior fiscal year period related to the COVID-19 pandemic. We continue to expect some volatility in the medical sector going forward.

The net decrease in the industrial sector of $3.4 million in the first nine months of fiscal 2021 compared to the same period of the prior fiscal year, resulted from decreases related to customer program delays of $1.2 million and net decreases in customer demand of $2.2 million.

Gross profit for the first nine months of fiscal 2021 was $14.3 million, or 10.0% of sales, compared to gross profit of $17.4 million, or 12.8% of sales in the first nine months of fiscal 2020, which included the negative impact of a one-time inventory reserve of $1.0 million related to a reorganization at one of our medical customers. Customer mix had the most significant impact on gross profit. During the first nine months of the prior fiscal year, due to the Chapter 11 bankruptcy filing of a customer, we incurred a $1.0 million pre-tax non-cash charge, related to the increase in our excess and obsolete inventory reserve. The customer communicated to its vendors to "cease providing all products" under its court-supervised process. No portion of the impairment charge is anticipated to result in future cash expenditures. We intend to preserve all rights and pursue available legal remedies to recover any losses suffered as a result of the customer's Chapter 11 bankruptcy filing. These charges impacted our financial results reported under accounting principles generally accepted in the United States of America ("GAAP") financial results. Net income in the first nine month of the prior fiscal year was $4.8 million, and, adjusted for the $1.0 million impact from the one-time inventory reserve, adjusted net income was $5.6 million. Information regarding this non-GAAP measure and a reconciliation of net income to adjusted net income is provided below under "Non-GAAP Financial Measures."

Selling and administrative expenses increased $0.2 million during the first nine months of fiscal 2021 compared to the first nine months of the prior fiscal year and represented 7.3% and 7.5% of sales in each of the periods, respectively.

Interest expense increased by $0.5 million in the first nine months of fiscal 2021 compared to the same period of the prior fiscal year. The weighted average interest rate on our debt was 0.72% lower during the first nine months of fiscal 2021 compared to the first nine months of the prior fiscal year. Our average outstanding debt balances increased by $5.0 million in the first nine months of fiscal 2021 compared to the first nine months of fiscal 2020 due to higher balances on our revolving credit facility and outstanding amounts under the Master Lease. Cash paid for interest on credit facility



                                       35

Table of Contents

debt was approximately $0.8 million during each of the first nine months of fiscal 2021 and fiscal 2020. Detailed information regarding our borrowings is provided in Note 6-Credit Facilities.

With respect to tax payments, in the near term, we expect to benefit from sizable NOL carryforwards for federal income tax purposes. During the first nine months of fiscal 2021, we paid minimal taxes. At the end of fiscal 2020, the gross NOL carryforwards amounted to approximately $15.9 million. The NOL carryforwards expire in 2036, unless utilized prior to these dates.

Non-GAAP Financial Measures

In addition to reporting net income, gross profit, gross margin and net income per basic and diluted share, U.S. GAAP measures, we present adjusted net income, adjusted gross profit, adjusted gross margin, adjusted net income per common share, basic and adjusted net income per common share, diluted, which are non-GAAP measures, to reflect the impact of a one-time inventory reserve related to a customer's bankruptcy. We believe these non-GAAP measures are important measures of our performance because they allow management, investors and others to evaluate and compare our performance from period to period by removing the impact of the one-time inventory reserve related to a customer's bankruptcy. Adjusted net income, adjusted gross profit, adjusted gross margin, adjusted net income per common share, basic and adjusted net income per common share, diluted are not measures of financial performance under GAAP and are not calculated through the application of GAAP. As such, they should not be considered as a substitute for the GAAP measures of net income gross profit, gross margin and net income per basic and diluted share, and therefore, should not be used in isolation of, but in conjunction with, the GAAP measures. These non-GAAP measures may produce results that vary from the GAAP measures and may not be comparable to a similarly titled non-GAAP measure used by other companies.




                                                           Nine Months Ended
                                                             June 26, 2020
Reconciliation of adjusted gross profit:
Gross profit                                              $          17,384
Non-cash charge (1)                                                     987
Adjusted gross profit                                     $          18,371

Reconciliation of adjusted gross margin:
Gross margin                                                           12.8 %
Non-cash charge (1)                                                     0.7 %
Adjusted gross margin                                                  13.5 %

Reconciliation of adjusted net income:
Net income                                                $           4,826
Non-cash charge (1)                                                     987
Income tax effect (2)                                                 (207)
Adjusted net income                                       $           5,606

Reconciliation of adjusted net income per common share: Net income per common share, basic

                        $            0.46
Non-cash charge, per common share, net of tax (1)(2)                   0.08
Adjusted net income per common share, basic               $            0.54

Net income per common share, diluted                      $            0.45
Non-cash charge, per common share, net of tax (1)(2)                   0.07
Adjusted net income per common share, diluted (3)         $            0.52




(1) A non-cash charge related to the increase in our excess and obsolete

inventory reserve due to the Chapter 11 bankruptcy filing of a customer of

IEC.

(2) The income tax effect related to the non-cash charge was calculated using an


    effective tax rate of 21%.


                                       36

  Table of Contents

(3) Adjusted net income per common share, diluted is calculated based on adjusted

net income and reflects the dilutive impact of shares, where applicable,

based on adjusted net income.

Liquidity and Capital Resources

Capital Resources

As of July 2, 2021, there were $1.8 million of outstanding capital expenditure commitments for manufacturing equipment. We generally fund capital expenditures with cash flows from operations, our revolving credit facility and the Master Lease. Based on our current expectations, we believe that our projected cash flows provided by operations and potential borrowings under the revolving credit facility and the Master Lease are sufficient to meet our working capital, debt service and capital expenditure requirements for the next twelve months.

Our cash management system provides for the funding of the disbursement accounts on a daily basis as checks are presented for payment. Under this system, outstanding checks in excess of the bank balance create a book overdraft.

© Edgar Online, source Glimpses